Stanford University
Showing 41-50 of 1,585 Results
-
Krishna Raghavan
Ph.D. Student in Chemistry, admitted Autumn 2024
BioKrishna is originally from the Detroit area of Michigan, and completed his undergraduate studies in biological chemistry and chemistry at the University of Chicago. He is currently a second-year PhD student concentrating in biophysical chemistry, in the lab of Prof. Bianxiao Cui.
-
Srinivas Raghu
Professor of Physics
BioI am interested in the emergent behavior of quantum condensed matter systems. Some recent research topics include non-Fermi liquids, quantum criticality, statistical mechanics of strongly interacting and disordered quantum systems, physics of the half-filled Landau level, quantum Hall to insulator transitions, superconductor-metal-insulator transitions, and the phenomenology of quantum materials.
Past contributions that I'm particularly proud of include the co-founding of the subject of topological photonics (with Duncan Haldane), scaling theories of non-Fermi liquid metals (with Shamit Kachru and Gonzalo Torroba), Euclidean lattice descriptions of Chern-Simons matter theories and their dualities in 2+1 dimensions (with Jing-Yuan Chen and Jun Ho Son), and 'dual' perspectives of quantum Hall transitions (with Prashant Kumar and Michael Mulligan). -
Amer Raheemullah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Amer Raheemullah, MD, is Associate Clinical Professor of Psychiatry and Behavioral Sciences at Stanford University. He is the Director of Stanford Hospital Addiction Services (shas.stanford.edu), which he initially launched at a single site, and after demonstrating significant improvements in patient outcomes, led its expansion across Stanford’s multiple hospital sites.
His research and insights on habits and addictive behavior have been published in leading journals including JAMA and Cambridge University Press, and has been featured in media outlets such as Bloomberg News, ABC7 News, KQED, and Everyday Health. He has been invited to advise on national addiction policy by the U.S. Food and Drug Administration (FDA), the U.S. Department of Health and Human Services (HHS), the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as the Congress-established Reagan-Udall Foundation. He has also consulted for several Silicon Valley digital health startups focused on habits and addictive behaviors, such as Lucid Lane, where he led the development and expansion of clinical programs that enabled the organization to grow from a single-state initiative into a nationally operating program within a few years.
His academic work focuses on translating research into scalable models of addiction treatment that can be integrated into health care systems, digital health interventions, and public policy to expand access to high-quality, evidence-based care. Since completing his addiction medicine training at Stanford University School of Medicine, he has continued to work directly with patients across a wide range of settings, including community-based programs, sober living environments, outpatient clinics, residential treatment facilities, inpatient units, and correctional settings.
